Central Trust Company’s Globus Medical GMED Stock Holding History

Central Trust Company’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.7K	Buy	159 +4	+3%	+$359	﹤0.01%	1090
2025 Q4	$13.5K	Sell	155 -150	-49%	-$11.4K	﹤0.01%	1069
2025 Q3	$17.5K	Sell	305 -361	-54%	-$20.8K	﹤0.01%	1013
2025 Q2	$39.3K	Buy	+666	New	+$43K	﹤0.01%	849
2018 Q4	–	Sell	-230	Closed	-$13K	–	1189
2018 Q3	$13K	Hold	230	–	–	﹤0.01%	929
2018 Q2	$12K	Buy	+230	New	+$12K	﹤0.01%	937
2016 Q3	–	Sell	-1,979	Closed	-$47K	–	1131
2016 Q2	$47K	Hold	1,979	–	–	﹤0.01%	689
2016 Q1	$47K	Buy	1,979 +356	+22%	+$8.7K	﹤0.01%	692
2015 Q4	$45K	Buy	1,623 +729	+82%	+$18.3K	﹤0.01%	668
2015 Q3	$18K	Buy	894 +327	+58%	+$8.28K	﹤0.01%	860
2015 Q2	$15K	Sell	567 -56	-9%	-$1.42K	﹤0.01%	921
2015 Q1	$16K	Hold	623	–	–	﹤0.01%	887
2014 Q4	$15K	Sell	623 -47	-7%	-$1.04K	﹤0.01%	899
2014 Q3	$13K	Buy	+670	New	+$13.8K	﹤0.01%	936

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Central Trust Company's GMED Position: Q1 2026 in Review

Central Trust Company increased its Globus Medical (GMED) stake by 2.6% in Q1 2026, buying an estimated $359 and bringing the position to 159 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Central Trust Company first reported a position in GMED in Q3 2014 and has held it in 14 quarters since. The position peaked at $47K in Q2 2016. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Central Trust Company held 159 shares of Globus Medical worth $13.7K as of Q1 2026.
Central Trust Company bought 4 Globus Medical shares in Q1 2026, an estimated $359.
Globus Medical made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #1090 holding.
Central Trust Company first reported a position in Globus Medical in Q3 2014 and has held it in 14 quarters since.
Central Trust Company's Globus Medical position peaked at $47K in Q2 2016.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.